Global University Venturing

A survey found a 16 percentage point rise in the number of Brazilian corporations investing in startups.

Pfizer has leapt to the top of the most active corporate venturing investors in US healthcare deals for the first half of 2016, as Novartis falls out of the top 10.

Johnson & Johnson invested $6m to help radiotherapy equipment developer Reflexion Medical close out its Pfizer-backed series B round at $52m.

Celgene has supported a funding round for Oncorus, an immuno-oncology treatment developer exploiting research conducted at Pittsburgh.

Oxford spinout Immago Biosystems, which is working on increasing the efficiency of antibody-based cancer therapies, has been acquired by Hansa Medical.

VIB-affiliated V-Bio Ventures has joined a series A round for the retinal treatment developer that already included Imperial Innovations.

Civil Maps, a startup working on autonomous car mapping technology, has raised $6.6m in a seed round that will fund product development.

The Edinburgh spinout, which uses LED light to wirelessly transmit data, has attracted series B capital from a consortium led by Temasek, the investment arm of Singapore's government.

Second Genome, which is applying genomics technology to the microbiome, is the latest in a growing string of gene technology companies to raise substantial funding.

The waste heat-to-energy technology developer has raised $23.5m in a series C round led by Schlumberger and backed by GM Ventures.

The news roundup for the week ending 15 July 2016.